A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

Clinical trial NCT05394831 · RECRUITING

Trial details

NCT number: NCT05394831
Sponsor: J Ints Bio
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EGFR Mutant Advanced Non-small Cell Lung Cancer

Start date: 2023-07-30
Primary completion: 2026-09-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.